This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Azevedo, E. R. Articles by Parker, J. D. Search for Related Content PubMed PubMed Citation Articles by Azevedo, E. R. Articles by Parker, J. D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Heart Failure Related Collections Congestive

(Circulation. 2000;101:2053.)
© 2000 American Heart Association, Inc.

Clinical Investigation and Reports

Reducing Cardiac Filling Pressure Lowers Norepinephrine Spillover in Patients With Chronic Heart Failure

Eduardo R. Azevedo, MD; Gary E. Newton, MD; John S. Floras, MD, DPhil; John D. Parker, MD

From the Division of Cardiology, Department of Medicine, Mount Sinai Hospital, University of Toronto.

Correspondence to John D. Parker, MD, Mount Sinai Hospital, 600 University Ave, Suite 1609, Toronto, Ontario M5G-1X5. E-mail jdp{at}inforamp.net

Background—We studied the cardiac sympathetic response to selective unloading of cardiopulmonary baroreceptors in subjects with normal left ventricular (LV) function and congestive heart failure (CHF).

Methods and Results—Eight patients with normal LV function (age 57±5 years, ejection fraction 58±2%) and 8 patients with CHF (age 60±2 years; ejection fraction 19±2%) were studied. Instrumentation consisted of an arterial line, a pulmonary artery catheter, and a coronary sinus thermodilution catheter. The radiotracer technique was used for measurement of cardiac norepinephrine spillover (CANESP) and total-body norepinephrine spillover. Lower-body negative pressure (LBNP) was applied at 2 levels: nonhypotensive and hypotensive LBNP. Nonhypotensive LBNP reduced filling pressures significantly in both groups. Arterial pressure did not change. This reduction in filling pressures caused a significant reduction in CANESP in the CHF group (from 167±53 to 125±37 pmol/min, P<0.05) but no change in the normal LV function group. Hypotensive LBNP caused a significant increase in CANESP in the normal group (73±13 vs 122±27 pmol/min, P<0.05) but no significant change in those with CHF.

Conclusions—We conclude that selective reduction in filling pressures lowers cardiac norepinephrine spillover in patients with CHF. These findings suggest that a goal of CHF management should be to reduce cardiac filling pressures while avoiding systemic hypotension.

Key Words: nervous system, autonomic • norepinephrine • nervous system, sympathetic

This article has been cited by other articles:

				A. M. D. Watson, S. G. Hood, R. Ramchandra, R. M. McAllen, and C. N. May Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H798 - H804. [Abstract] [Full Text] [PDF]

				A. Ciarka, J.-L. Vachiery, A. Houssiere, M. Gujic, E. Stoupel, S. Velez-Roa, R. Naeije, and P. van de Borne Atrial Septostomy Decreases Sympathetic Overactivity in Pulmonary Arterial Hypertension Chest, June 1, 2007; 131(6): 1831 - 1837. [Abstract] [Full Text] [PDF]

				P. A. Gould, M. Yii, M. D. Esler, J. M. Power, and D. M. Kaye Atrial fibrillation impairs cardiac sympathetic response to baroreceptor unloading in congestive heart failure Eur. Heart J., December 1, 2005; 26(23): 2562 - 2567. [Abstract] [Full Text] [PDF]

				J. S. Floras Atrial fibrillation and cardiac sympathetic reflexes in heart failure Eur. Heart J., December 1, 2005; 26(23): 2490 - 2492. [Full Text] [PDF]

				D. Kaye and M. Esler Sympathetic neuronal regulation of the heart in aging and heart failure Cardiovasc Res, May 1, 2005; 66(2): 256 - 264. [Abstract] [Full Text] [PDF]

				A. Al-Hesayen and J. D. Parker Impaired Baroreceptor Control of Renal Sympathetic Activity in Human Chronic Heart Failure Circulation, June 15, 2004; 109(23): 2862 - 2865. [Abstract] [Full Text] [PDF]

				M. P. Schlaich, D. M. Kaye, E. Lambert, M. Sommerville, F. Socratous, and M. D. Esler Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy Circulation, August 5, 2003; 108(5): 560 - 565. [Abstract] [Full Text] [PDF]

				R. S. T. Leung, M. E. Bowman, J. D. Parker, G. E. Newton, and T. D. Bradley Avoidance of the left lateral decubitus position during sleep in patients with heart failure: relationship to cardiac size and function J. Am. Coll. Cardiol., January 15, 2003; 41(2): 227 - 230. [Abstract] [Full Text] [PDF]

				C.-S. Liang, Y. Himura, M. Kashiki, and S. Y. Stevens Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1863 - H1872. [Abstract] [Full Text] [PDF]

				D.M. Kaye Alterations in oxygen consumption and sympathetic nervous activity in heart failure: independent or associated mechanisms? Eur. Heart J., May 2, 2002; 23(10): 764 - 766. [Full Text] [PDF]

				C.F. Notarius, E.R. Azevedo, J.D. Parker, and J.S. Floras Peak oxygen uptake is not determined by cardiac noradrenaline spillover in heart failure Eur. Heart J., May 2, 2002; 23(10): 800 - 805. [Abstract] [Full Text] [PDF]

				A. Al-Hesayen, E. R. Azevedo, G. E. Newton, and J. D. Parker The effects of dobutamine on cardiac sympathetic activity in patients with congestive heart failure J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1269 - 1274. [Abstract] [Full Text] [PDF]

				J. S. Floras The "Unsympathetic" Nervous System of Heart Failure Circulation, April 16, 2002; 105(15): 1753 - 1755. [Full Text] [PDF]

				A. Nohria, E. Lewis, and L. W. Stevenson Medical Management of Advanced Heart Failure JAMA, February 6, 2002; 287(5): 628 - 640. [Abstract] [Full Text] [PDF]

				M. H. Drazner, J. E. Rame, L. W. Stevenson, and D. L. Dries Prognostic Importance of Elevated Jugular Venous Pressure and a Third Heart Sound in Patients with Heart Failure N. Engl. J. Med., August 23, 2001; 345(8): 574 - 581. [Abstract] [Full Text] [PDF]

				J. S. Floras, G. C. Butler, S.-I. Ando, S. C. Brooks, M. J. Pollard, and P. Picton Differential sympathetic nerve and heart rate spectral effects of nonhypotensive lower body negative pressure Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R468 - R475. [Abstract] [Full Text] [PDF]

				Y. Goso, H. Asanoi, H. Ishise, T. Kameyama, T. Hirai, T. Nozawa, S. Takashima, K. Umeno, and H. Inoue Respiratory Modulation of Muscle Sympathetic Nerve Activity in Patients With Chronic Heart Failure Circulation, July 24, 2001; 104(4): 418 - 423. [Abstract] [Full Text] [PDF]

				D. M. Kaye, D. Mansfield, A. Aggarwal, M. T. Naughton, and M. D. Esler Acute Effects of Continuous Positive Airway Pressure on Cardiac Sympathetic Tone in Congestive Heart Failure Circulation, May 15, 2001; 103(19): 2336 - 2338. [Abstract] [Full Text] [PDF]

				H. P. Brunner-La Rocca, D. M. Kaye, R. L. Woods, J. Hastings, and M. D. Esler Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1221 - 1227. [Abstract] [Full Text] [PDF]

				C. F. Notarius and J. S. Floras Limitations of the use of spectral analysis of heart rate variability for the estimation of cardiac sympathetic activity in heart failure Europace, January 1, 2001; 3(1): 29 - 38. [Abstract] [PDF]